Records containing: Recurrent Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-04-10Phase 1 Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, NSC #707545) in Patients With Solid Tumors.
-
CLINICAL_TRIALS study record update · 2013-04-10Phase II Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) Diluted in EPL Diluent (NSC #704057) in Metastatic Melanoma Patients
-
CLINICAL_TRIALS study record update · 2013-03-05A Phase II Trial of PS-341 in Combination With Paclitaxel and Carboplatin for the Treatment of Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-02-07A Phase I Study Of The Toxicities, Biologic And Clinical Effects Of Daily 5 Aza 2'Deoxycytidine (DAC), NSC 127716 (IND 50733) For Four Weeks In Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-01-25A Phase II Study Of Epothilone B Analog BMS 247550 (NSC # 710428) In Stage IV Malignant Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-25Melanoma Vaccines: Differentiation Antigen Peptides (MART-1:27-35, Tyrosinase and Gp-100) as Immune Targets
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase II Trial of SU5416 (NSC #696819) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase II Study Of Temozolomide And Thalidomide In Patients With Metastatic Melanoma In The Brain
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase II, Pharmacokinetic (PK), Pharmacodynamic (PD) and Biological Correlative Study of the Efficacy and Safety of Dual Antiangiogenic Inhibition Using Bevacizumab and Sorafenib in Patients With Advanced Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-01-16Phase II Study of Melanoma Vaccine (NSC #683472/675756, IND #6123) and Low-Dose, Subcutaneous Interleukin-2 in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2013-01-16A Phase II Study of PS-341 in the Treatment of Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2012-09-27A Double-Blind, Randomized, Placebo-Controlled Phase III Trial of Carboplatin, Paclitaxel and Sorafenib Versus Carboplatin, Paclitaxel and Placebo in Patients With Unresectable Locally Advanced or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2012-07-10A Randomized Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) With Either CCI-779 (Temsirolimus; NSC-683864) or R115777 (Tipifarnib; NSC-702818) in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-03-16Phase I Study To Evaluate Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following Cyclophosphamide Conditioning For Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-07-07Phase II Study of Allovectin-7 as an Immunotherapeutic Agent in Patients With Stages III and IV Melanoma
-
CLINICAL_TRIALS study record update · 2008-07-25Phase III Randomized Study of Dacarbazine With or Without Allovectin-7 in Patients With Metastatic Melanoma